Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Angewandte Chemie (International Ed. in English)|April 12, 2022
Lattice-Confined Single-Atom Fe<sub>1</sub> S<sub>x</sub> on Mesoporous TiO<sub>2</sub> for Boosting Ambient Electrocatalytic N<sub>2</sub> Reduction ReactionJiayin Chen, Yikun Kang, Wei Zhang, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 29, 2021
Interface Engineering of Co-LDH@MOF Heterojunction in Highly Stable and Efficient Oxygen Evolution ReactionZhenxing Li, Xin Zhang, Yikun Kang, et al.Cancer Biology & Medicine|May 5, 2023
Combined chemo-endocrine therapy as a potential new option for HR+/HER2- advanced breast cancer: a prospective study of fulvestrant plus oral vinorelbineXue Wang, Jian Yue, Yikun Kang, et al.Journal of Translational Medicine|November 14, 2023
Liquid-based biomarkers in breast cancer: looking beyond the bloodYou Shuai, Zhonghua Ma, Jie Ju, et al.Small (Weinheim an Der Bergstrasse, Germany)|December 7, 2019
An Interfacial Electron Transfer on Tetrahedral NiS<sub>2</sub> /NiSe<sub>2</sub> Heterocages with Dual-Phase Synergy for Efficiently Triggering the Oxygen Evolution ReactionYang Yang, Yikun Kang, Huihui Zhao, et al.Frontiers in Oncology|February 23, 2023
Clinicopathologic characteristics and prognostic significance of HER2-low expression in patients with early breast cancer: A systematic review and meta-analysisTong Wei, Dingyuan Wang, Songlin Gao, et al.Angewandte Chemie (International Ed. in English)|October 20, 2022
Electrifying Adipic Acid Production: Copper-Promoted Oxidation and C-C Cleavage of CyclohexanolRan Wang, Yikun Kang, Jianxiang Wu, et al.Analytical Chemistry|September 3, 2021
Axial Ligand-Engineered Single-Atom Catalysts with Boosted Enzyme-Like Activity for Sensitive ImmunoassayWeiqing Xu, Weiyu Song, Yikun Kang, et al.Angewandte Chemie (International Ed. in English)|June 6, 2023
Electrode/Electrolyte Synergy for Concerted Promotion of Electron and Proton Transfers toward Efficient Neutral Water OxidationYaming Hao, Yikun Kang, Shaoyan Wang, et al.JAMA Network Open|February 24, 2023
Effect of Epirubicin Plus Paclitaxel vs Epirubicin and Cyclophosphamide Followed by Paclitaxel on Disease-Free Survival Among Patients With Operable ERBB2-Negative and Lymph Node-Positive Breast Cancer: A Randomized Clinical TrialPeng Yuan, Yikun Kang, Fei Ma, et al.Pageof 3